http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103910775-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e620a405205ac610fedc78b03f87be94
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
filingDate 2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89f8d54c5fbd70300963e9b9f0e42aea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d72595d477323df076bdf30fbcc8d03c
publicationDate 2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103910775-A
titleOfInvention Synthetic method of 17α-hydroxyprogesterone
abstract The invention discloses a synthesis method of 17α-hydroxyprogesterone, which uses 4-androstene-dione as a starting material, undergoes cyanation with acetone cyanohydrin, protects the 3-position carbonyl with triethyl orthoformate and ethanol, and uses Vinyl butyl ether protects the 17-hydroxyl group, and after Grignard reaction, it is hydrolyzed to generate 17α-hydroxy progesterone. The invention can reduce cost, reduce environmental pollution, shorten reaction time, simplify industrial production post-treatment process, greatly save production time and cost, increase production capacity, and facilitate industrial implementation. Compared with the traditional process, the present invention has the characteristics of low raw material cost, simple and convenient method, high yield, good selectivity, mild reaction conditions, little pollution, applicable to industrialized production, stable method and easy realization.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109369764-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109369763-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104327146-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749465-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105693803-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107286215-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104926906-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109456382-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107011402-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104072565-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109627276-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109627275-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108033990-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112175034-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109438540-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104072565-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109535214-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112725296-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112175034-B
priorityDate 2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8803534-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102180878-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148104080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409920041

Total number of triples: 34.